H1 2025 Recap: Key Signals from the Tech+Bio Frontier
A high-signal summary of some of the most important moves and trends shaping biotech and tech-enabled life sciences in the first half of 2025.
In this issue: Financial Climate & Deal-Making Power Shift — Gene Therapies are a Mixed Bag — AI Drug Discovery is Recalibrating — Big Data & Data Infrastructures Define Leaders — a Year of Next Generation Sequencing — Away from Animal Models — Brain-Computer Interfaces are Having Momentum
Read this Pro article free
Subscribe to BiopharmaTrend Insider, our free biweekly briefing on what matters in tech and bio, and get one free Pro article every month, starting with this one.
Insider arrives every two weeks, plus a short note when we publish a new deep dive. Unsubscribe anytime. Articles you unlock stay unlocked.
Already subscribed? Sign in here.
